What is a mycotic aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Mycotic Aneurysm?

A mycotic aneurysm is an infected aneurysm of a blood vessel caused by microbial invasion of the arterial wall, most commonly by bacteria (despite the misleading term "mycotic" which historically referred to its mushroom-like appearance rather than fungal etiology). 1

Historical Context and Terminology

The term "mycotic aneurysm" was coined by William Osler in 1885 to describe the mushroom-like appearance of infected aneurysms associated with bacterial endocarditis, not because they were caused by fungi. 2, 3, 4 This creates ongoing confusion since "mycotic" by definition suggests fungal origin, yet the vast majority are bacterial. 3 True fungal aneurysms are exceedingly rare, with only seven cases reported between 1966-1999. 3

It is critical to distinguish mycotic aneurysms from syphilitic aneurysms, which develop through a completely different chronic inflammatory mechanism 10-25 years after initial spirochetal infection and predominantly affect the ascending thoracic aorta as fusiform aneurysms. 5, 6 Syphilitic aneurysms are not acute infectious processes like true mycotic aneurysms. 6

Epidemiology and Location

Mycotic aneurysms are rare, accounting for only 0.7% to 4.5% of all aortic aneurysms and approximately 0.6% of aneurysms overall in Western countries. 1, 2 The distribution by location is: 1

  • Abdominal aorta: ~70% (predominantly suprarenal, unlike atherosclerotic aneurysms which are 85% infrarenal)
  • Thoracic aorta: ~30%
  • Visceral arteries: <1%
  • Intracranial arteries: 0.7-6.5% of all intracranial aneurysms, most commonly in the middle cerebral artery (44% of cases) 5

Men predominate over women by 3:1, with average age >65 years, and strong associations with cigarette smoking and diabetes mellitus. 1

Pathophysiology: Five Key Mechanisms

The American Heart Association describes five distinct mechanisms for mycotic aneurysm development: 1

  1. Infected atherosclerotic plaque: The normal aortic intima resists infection, but damaged endothelium from atherosclerotic plaques or ulcers can be colonized during bacteremia, leading to infected atherosclerotic aneurysm formation. 1

  2. Vasa vasorum infection: Bacteremic or contiguous spread to the vasa vasorum proceeds inward toward the vessel wall, causing localized infection with wall thinning and aneurysm development. 1

  3. Contiguous spread: Infection extends from gastrointestinal sources (especially Salmonella gastroenteritis) or vertebral osteomyelitis, creating primary abdominal aortic mycotic aneurysms or secondarily infecting preexisting atherosclerotic aneurysms. 1

  4. Congenital abnormalities: Endothelial damage from cystic necrosis or coarctation makes vessels susceptible to infection from bacteremia or contiguous spread. 1

  5. Cardiac surgery-related: Mycotic aneurysms in the sinus of Valsalva or aortic arch develop following reconstructive surgery, infective endocarditis, or prosthetic valve endocarditis. 1

Microbiology: Evolving Spectrum

The microbiological profile has shifted dramatically in recent years: 1

  • Staphylococci (S. aureus and coagulase-negative): Now the most common cause, accounting for 50-60% of cases 1
  • Gram-negative bacilli: Previously dominant, now 30-40% of cases 1
    • Salmonella species (especially nontyphoidal strains like S. enteritidis and S. choleraesuis): More common in Asia, with special predilection for vascular tissue; 25% of patients ≥50 years with Salmonella bacteremia have endovascular infection 1
    • Other gram-negatives including Arizona species, Pseudomonas aeruginosa 1, 2
  • Less common pathogens: Listeria monocytogenes, Mycobacterium tuberculosis (via vertebral osteomyelitis erosion), Streptococcus pneumoniae, anaerobes 1, 2
  • Fungi: Candida and Aspergillus species are rare but reported 1, 3

Clinical Presentation: Nonspecific but Critical Features

The classic triad of fever, pain, and pulsatile abdominal mass is actually uncommon. 1, 7 More realistic presentations include: 1

  • Fever: Present in ≥70% of intra-abdominal cases (uncommon in uninfected atherosclerotic aneurysms) 1
  • Back pain: 65-90% of cases (less common in uninfected aneurysms) 1
  • Intrathoracic mycotic aneurysms: Fever, chest and interscapular pain, findings of infective endocarditis or prosthetic valve infection 1
  • Visceral artery involvement:
    • Superior mesenteric: Acute abdominal pain, fever, rarely palpable epigastric mass, potentially catastrophic GI hemorrhage 1
    • Hepatic artery: Fever, colicky upper abdominal pain, hemobilia, jaundice, GI hemorrhage 1
    • Renal artery: Fever, hematuria, elevated blood pressure 1

Catastrophic Complication: Rupture

Complete or contained rupture occurs in 50-75% of patients, with rupture sites including: 1

  • Retroperitoneal/peritoneal space (50%)
  • Duodenum (12%)
  • Pleural cavity (10%)
  • Esophagus, mediastinum, or pericardium (3-5%)

Impending or contained rupture presents with severe pain, hemodynamic instability, or sudden catastrophic rupture with shock and high mortality. 1

Diagnostic Approach

CT angiography (CTA) is the initial imaging procedure of choice, allowing rapid examination in potentially unstable patients requiring urgent surgical intervention. 1 CTA defines: 1

  • Precise location and vascular anatomy
  • Detection of impending rupture
  • Associated complications
  • Serial monitoring capability

Key imaging characteristics distinguishing mycotic from atherosclerotic aneurysms: 5

  • Saccular, lobular, or irregular morphology (vs. fusiform)
  • Minimal to absent calcification
  • Periaortic soft tissue stranding/inflammatory changes
  • Rapid enlargement on serial imaging

Laboratory findings are nonspecific: 1

  • Leukocytosis (65-85% of cases)
  • Elevated inflammatory markers (ESR, CRP in 75-80%)
  • Blood cultures positive in 50-90% of cases 5

Critical Clinical Pitfalls

  1. Do not confuse with inflammatory abdominal aortic aneurysms (5-10% of all AAAs), which occur in older men with smoking/diabetes history but fever is less common. 1

  2. Suspect aortoenteric fistula and mycotic aneurysm in patients with recent or remote AAA repair; up to 4% develop aortoenteric fistulae. 1

  3. In renal transplant recipients, consider mycotic aneurysm related to perinephric infections, particularly in the external iliac artery. 1

  4. Lumbar spine osteomyelitis is present in up to one-third of patients with Salmonella-caused aortic mycotic aneurysms. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multiple mycotic aneurysms with a rare fungus, Aspergillus niger: a complex case report.

Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing, 2008

Research

Mycotic popliteal artery aneurysm.

The Journal of the Association of Physicians of India, 2014

Guideline

Mycotic Aneurysm Coding Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Syphilitic Aneurysms and Aortitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bradycardia in Abdominal Aortic Aneurysm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.